These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28671950)

  • 21. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cell targeted therapy: progress amid controversies.
    Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
    Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of senescence in cancer cells by 5'-Aza-2'-deoxycytidine: Bioinformatics and experimental insights to its targets.
    Putri JF; Widodo N; Sakamoto K; Kaul SC; Wadhwa R
    Comput Biol Chem; 2017 Oct; 70():49-55. PubMed ID: 28802167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMPK and Cancer.
    Wang Z; Wang N; Liu P; Xie X
    Exp Suppl; 2016; 107():203-226. PubMed ID: 27812982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basic stem cell biology and cancer].
    Porse BT; Petersen OW; Helin K
    Ugeskr Laeger; 2010 Sep; 172(38):2600-3. PubMed ID: 20920403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.
    Shetzer Y; Molchadsky A; Rotter V
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27235476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling, property verification and behavioural equivalence of lactose operon regulation.
    Pinto MC; Foss L; Mombach JC; Ribeiro L
    Comput Biol Med; 2007 Feb; 37(2):134-48. PubMed ID: 16620804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From word models to executable models of signaling networks using automated assembly.
    Gyori BM; Bachman JA; Subramanian K; Muhlich JL; Galescu L; Sorger PK
    Mol Syst Biol; 2017 Nov; 13(11):954. PubMed ID: 29175850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic modeling and analysis of cancer cellular network motifs.
    Cloutier M; Wang E
    Integr Biol (Camb); 2011 Jul; 3(7):724-32. PubMed ID: 21674097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formal derivation of qualitative dynamical models from biochemical networks.
    Abou-Jaoudé W; Thieffry D; Feret J
    Biosystems; 2016 Nov; 149():70-112. PubMed ID: 27619217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology.
    Bianconi F; Baldelli E; Ludovini V; Petricoin EF; Crinò L; Valigi P
    BMC Syst Biol; 2015 Oct; 9():70. PubMed ID: 26482604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms promoting physiological cells progression into tumorigenesis.
    Korbut E; Ptak-Belowska A; Brzozowski T
    J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
    Ribeiro D; Pinto JM
    Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clonogenic cells in human tumors and the sensitivity to chemotherapy].
    Potapov SL; Korman DB
    Eksp Onkol; 1986; 8(1):7-12. PubMed ID: 3512239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal (meta-)logical reasoning: The Wise Men Puzzle (Isabelle/HOL dataset).
    Benzmüller C
    Data Brief; 2019 Jun; 24():103823. PubMed ID: 31016212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug target identification through systems biology.
    Haanstra JR; Bakker BM
    Drug Discov Today Technol; 2015 Aug; 15():17-22. PubMed ID: 26464086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systems biology analysis of autophagy in cancer therapy.
    Shi Z; Li CY; Zhao S; Yu Y; An N; Liu YX; Wu CF; Yue BS; Bao JK
    Cancer Lett; 2013 Sep; 337(2):149-60. PubMed ID: 23791881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells: beyond Koch's postulates.
    Garcion E; Naveilhan P; Berger F; Wion D
    Cancer Lett; 2009 Jun; 278(1):3-8. PubMed ID: 18922632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cancer initiation as mini-evolution].
    Iwasa Y
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(15):1962-9. PubMed ID: 16363646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.